Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Overview
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Blood Coagulants Market, by Type
6.1 Overview
6.2 Coagulation Factor
6.2.1 Recombinant Coagulation Factor
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.2.2 Plasma-Derived Coagulation Factor
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
6.3 Others
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
Chapter 7. Global Blood Coagulants Market, by Indication
7.1 Overview
7.2 Hemophilia
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.3 Surgery
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
7.4 Other Bleeding Disorders
Market Estimates & Forecast, by Region, 2022–2030
Market Estimates & Forecast, by Country, 2022–2030
Chapter 8. Global Blood Coagulants Market, by Region
8.1 Overview
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 Latin America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 France
8.3.1.3 Italy
8.3.1.4 Spain
8.3.1.5 UK
8.3.1.6 Rest of Western Europe
8.3.2 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
Chapter 9. Company Landscape
9.1 Overview
9.2 Market Share Analysis
Chapter 10. Company Profiles
10.1 Aptevo Biotherapeutics LLC
10.1.1 Company Overview
10.1.2 Product Overview
10.1.3 Financials Overview
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.2 Baxalta US Inc.
10.2.1 Company Overview
10.2.2 Product Overview
10.2.3 Financial Overview
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.3 Baxter Laboratories
10.3.1 Company Overview
10.3.2 Product Overview
10.3.3 Financial Overview
10.3.4 Key Development
10.3.5 SWOT Analysis
10.4 Bayer AG
10.4.1 Company Overview
10.4.2 Product Overview
10.4.3 Financial Overview
10.4.4 Key Development
10.4.5 SWOT Analysis
10.5 CSL Behring
10.5.1 Company Overview
10.5.2 Product Overview
10.5.3 Financial overview
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.6 GRIFOLS USA, LLC
10.6.1 Company Overview
10.6.2 Product Overview
10.6.3 Financial Overview
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.7 Novo Nordisk A/S
10.7.1 Overview
10.7.2 Product Overview
10.7.3 Financial Overview
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.8 Octapharma
10.8.1 Overview
10.8.2 Product Overview
10.8.3 Financials
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.9 Pfizer
10.9.1 Overview
10.9.2 Product Overview
10.9.3 Financials
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.10 Shire
10.10.1 Overview
10.10.2 Product Overview
10.10.3 Financials
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.11 SOBI
10.11.1 Overview
10.11.2 Product Overview
10.11.3 Financials
10.11.4 Key Developments
10.11.5 SWOT Analysis
10.12 Others
Chapter 11 MRFR Conclusion
11.1 Key Findings
11.1.1 From CEO’s Viewpoint
11.1.2 Unmet Needs of the Market
11.3 Predictions for the Blood Coagulants Industry
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Blood Coagulants Market Synopsis, 2022–2030
Table 2 Global Blood Coagulants Market Estimates and Forecast, 2022–2030 (USD Million)
Table 3 Global Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 4 Global Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 5 Global Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 6 North America: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 7 North America: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 8 North America: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 9 US: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 10 US: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 11 US: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 12 Canada: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 13 Canada: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 14 Canada: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 15 South America: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 16 South America: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 17 South America: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 18 Europe: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 19 Europe: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 20 Europe: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 21 Western Europe: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 22 Western Europe: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 23 Western Europe: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 24 Eastern Europe: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 25 Eastern Europe: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 26 Eastern Europe: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 27 Asia-Pacific: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 28 Asia-Pacific: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 29 Asia-Pacific: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
Table 30 Middle East & Africa: Blood Coagulants Market, by Type, 2022–2030 (USD Million)
Table 31 Middle East & Africa: Blood Coagulants Market, by Indication, 2022–2030 (USD Million)
Table 32 Middle East & Africa: Blood Coagulants Market, by Region, 2022–2030 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Blood Coagulants Market
Figure 3 Segmentation Market Dynamics for Global Blood Coagulants Market
Figure 4 Global Blood Coagulants Market Share, by Type, 2022 (%)
Figure 5 Global Blood Coagulants Market Share, by Indication, 2022 (%)
Figure 6 Global Blood Coagulants Market Share, by Region, 2022 (%)
Figure 7 North America: Blood Coagulants Market Share, by Country, 2022 (%)
Figure 8 Europe: Blood Coagulants Market Share, by Country, 2022 (%)
Figure 9 Asia-Pacific: Blood Coagulants Market Share, by Country, 2022 (%)
Figure 10 Middle East & Africa: Blood Coagulants Market Share, by Country, 2022 (%)
Figure 11 Global Blood Coagulants Market: Company Share Analysis, 2022 (%)
Figure 12 Aptevo Biotherapeutics LLC: Key Financials
Figure 13 Aptevo Biotherapeutics LLC: Segmental Revenue
Figure 14 Aptevo Biotherapeutics LLC: Geographical Revenue
Figure 15 Baxalta US Inc.: Key Financials
Figure 16 Baxalta US Inc.: Segmental Revenue
Figure 17 Baxalta US Inc.: Geographical Revenue
Figure 18 Baxter Laboratories: Key Financials
Figure 19 Baxter Laboratories: Segmental Revenue
Figure 20 Baxter Laboratories: Geographical Revenue
Figure 21 Bayer AG: Key Financials
Figure 22 Bayer AG: Segmental Revenue
Figure 23 Bayer AG: Geographical Revenue
Figure 24 CSL Behring: Key Financials
Figure 25 CSL Behring: Segmental Revenue
Figure 26 CSL Behring: Geographical Revenue
Figure 27 GRIFOLS USA, LLC: Key Financials
Figure 28 GRIFOLS USA, LLC: Segmental Revenue
Figure 29 GRIFOLS USA, LLC: Geographical Revenue
Figure 30 Novo Nordisk A/S: Key Financials
Figure 31 Novo Nordisk A/S: Segmental Revenue
Figure 32 Novo Nordisk A/S: Geographical Revenue
Figure 33 Octapharma: Key Financials
Figure 34 Octapharma: Segmental Revenue
Figure 35 Octapharma: Geographical Revenue
Figure 36 Pfizer: Key Financials
Figure 37 Pfizer: Segmental Revenue
Figure 38 Pfizer: Geographical Revenue
Figure 39 Shire: Key Financials
Figure 40 Shire: Segmental Revenue
Figure 41 Shire: Geographical Revenue
Figure 42 SOBI: Key Financials
Figure 43 SOBI: Segmental Revenue
Figure 44 SOBI: Geographical Revenue
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
